Le Lézard
Classified in: Science and technology
Subjects: Conference, Event

E2open Kicks Off Connect 2023, its Flagship Supply Chain Event


E2open Parent Holdings, Inc. (NYSE: ETWO), the connected supply chain SaaS platform with the largest multi-enterprise network, announces the kick-off of its annual client conference, Connect 2023 in Orlando, Florida from September 11-14, 2023. This year's conference focuses on streamlining and connecting supply chain operations amid a disruptive mix of events from trade issues to rising costs that have had far-reaching effects on global supply chain networks, including sales channels.

Keynote speakers including New York Times best-selling author and Paralympic medalist Amy Purdy and IDC Group Vice President Simon Ellis will join presenters from e2open, client speakers across a range of industries, and strategic and technology partners to deliver 45 educational sessions.

In addition to sessions covering e2open's technology platform across channel, planning, global trade, logistics and supply, e2open will showcase two strategic initiatives that reflect the ways supply chain ecosystems are becoming more interconnected and complex:

"Companies face expected but unpredictable disruptions that underscore the necessity to build resiliency in their supply chains," said Michael Farlekas, chief executive officer of e2open. "To do this, enterprises must be connected ? it's a prerequisite for real-time visibility and orchestration across supply chains, and essential to reaching autonomous decision-making; this is the value that e2open's network and platform provide. We look forward to spending time with our clients and partners at Connect, to exchange insights and share our innovations to accelerate and multiply the value we deliver to power the next generation of supply chain operations."

Prestige sponsors of Connect are Accenture, Amazon Freight, and Everstream Analytics, along with title golf sponsor, KPMG.

For more information, visit: connect.e2open.com.

About e2open

E2open is the connected supply chain software platform that enables the world's largest companies to transform the way they make, move, and sell goods and services. With the broadest cloud-native global platform purpose-built for modern supply chains, e2open connects more than 420,000 manufacturing, logistics, channel, and distribution partners as one multi-enterprise network tracking over 14 billion transactions annually. Our SaaS platform anticipates disruptions and opportunities to help companies improve efficiency, reduce waste, and operate sustainably. Moving as one.tm Learn More: www.e2open.com.

E2open and "Moving as one." are the registered trademarks of E2open, LLC. All other trademarks, registered trademarks and service marks are the property of their respective owners.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: